FIELD: organic chemistry, medicine.
SUBSTANCE: invention relates to bicyclic heterocyclic substituted phenyloxazolidinones that represent compounds of the formula (I): wherein R is taken from the group consisting of -OH, O-heteroaryl, -N3, -OSO2R'', -NR'''R'''', or the formula: wherein: (ii) R'' represents direct or branched alkyl comprising up to 5 carbon atoms; (iii) R''' and R'''' are taken independently from the group consisting of hydrogen atom (H), -CO2-R1, -CO-R1, -CS-R1 and -SO2-R4 wherein R1 is taken among the group consisting of cycloalkyl comprising from 3 to 6 carbon atoms and direct or branched alkyl comprising up to 6 carbon atoms; R4 is taken from direct or branched alkyl comprising up to 4 carbon atoms; and R4a represents -CN or -NO2; R4b represents -SR4c, amino-group, -NHR4c or -NR4cR4d wherein R4c and R4d are taken independently from hydrogen atom (H) or alkyl; X represents from 0 to 4 members taken independently from the group consisting of halogen atom; and Y represents radical of the formula (II): or (III): wherein R5, R6, R7 and R8 represent independently hydrogen atom (H), or R and R6 and/or R7 and R8 form in common oxo-group; R9 and R10 represent independently hydrogen atom (H); A, B, C and D are taken from carbon atom (C) and nitrogen atom (N) to form phenyl ring or 5-6-membered heteroaromatic ring wherein the indicated heteroaromatic ring comprises from 1 to 4 members taken from the group consisting of nitrogen atom (N); Z is taken from alkyl, heteroaryl comprising nitrogen atom (N); and m represents 0 or 1. These compounds are useful as antibacterial agents and can be used for treatment of patient with the state caused the bacterial infection or with the bacterial infection caused by S. aureus and E. faecium.
EFFECT: valuable medicinal properties of compounds.
45 cl, 1 tbl, 50 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
DERIVATIVES OF IMIDAZOLE AS INHIBITORS OF PRENYL TRANSFERASE, PHARMACEUTICAL COMPOSITION AND METHODS FOR TREATMENT BASED ON THEREOF | 1999 |
|
RU2241712C9 |
SYMMETRIC AND ASYMMETRIC DERIVATIVES OF DIPHENYLUREA (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITION OF RAF KINASE- MEDIATED TUMOR CELLS PROLIFERATION | 1998 |
|
RU2247109C9 |
SPIROPIPERIDINES, METHODS OF THEIR SYNTHESIS (VARIANTS) | 1993 |
|
RU2168512C2 |
INDOLOPYRROLOCARBAZOLE DERIVATIVES OF SUGARS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF INHIBITION OF TUMOR PROLIFERATION | 1997 |
|
RU2167880C2 |
DERIVATIVES OF PROPIONIC ACID (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FOR SELECTIVE INHIBITION OF αβ-INTEGRIN BINDING | 2000 |
|
RU2255933C9 |
BICYCLIC DERIVATIVES OF AMIDINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF NITROGEN OXIDE SYNTHETASE ACTIVITY | 1995 |
|
RU2155761C2 |
7-OXABICYCLOHEPTYL-SUBSTITUTED HETEROCYCLIC AMIDES OR STEREOISOMERS THEREOF AS THROMBOXANE RECEPTOR ANTAGONISTS | 1991 |
|
RU2015980C1 |
DERIVATIVES OF ANTHRANILIC ACID, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2195454C2 |
RACEMIC AND OPTIC ACTIVE DERIVATIVES OF TETRALIN AND 7-HYDROXYTETRALIN | 1992 |
|
RU2073673C1 |
Authors
Dates
2006-06-20—Published
2000-08-02—Filed